A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
NCT04015102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 255
Last updated 2020-11-05
Summary
This prospective registry will evaluate the feasibility and impact of implementing standard cancer family history review and guideline-aligned genetic testing for men diagnosed with Prostate Cancer in community urology practices nationwide.
Conditions
Sponsors & Collaborators
-
Carolina Urologic Research Center
collaborator OTHER -
Myriad Genetic Laboratories, Inc.
lead INDUSTRY
Principal Investigators
-
Neal Shore, MD · Carolina Urologic Research Center
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-06
- Primary Completion
- 2020-10-21
- Completion
- 2020-10-30
Countries
- United States
Study Locations
More Related Trials
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
Family History and Cancer Risk Study
NCT05079334 ·Status: ACTIVE_NOT_RECRUITING
-
Physicians Survey on Genetic Testing
NCT00341107 ·Status: COMPLETED
-
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer
NCT05958082 ·Status: RECRUITING ·Phase: NA
-
Prostate Cancer Genomic Heterogeneity
NCT02022371 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT02253251 ·Status: RECRUITING
-
Exploring Men s Prostate Cancer Genetic Risk Perceptions
NCT06764992 ·Status: COMPLETED
-
Strategic Targeting for Optimal Prevention of Cancer
NCT03897374 ·Status: RECRUITING
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Family History Study on Cancer Risk
NCT04145388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Inherited CAncer REgistry
NCT03231891 ·Status: RECRUITING
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
NCT03955913 ·Status: COMPLETED
-
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
NCT06060561 ·Status: SUSPENDED
-
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
NCT03030404 ·Status: COMPLETED
-
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
NCT01098552 ·Status: COMPLETED
-
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
NCT04920513 ·Status: COMPLETED
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008 ·Status: TERMINATED
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN
-
STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers
NCT06861621 ·Status: RECRUITING
-
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041 ·Status: RECRUITING ·Phase: NA
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
DNA Changes in Patients With Prostate Cancer
NCT00899184 ·Status: COMPLETED